Immediate Treatment for Priapism
The immediate treatment for ischemic priapism is corporal aspiration with a 19-21 gauge butterfly needle inserted into the lateral aspect of the proximal penis, followed by intracavernous injection of phenylephrine (100-500 μg diluted in saline) if aspiration alone is unsuccessful. 1
Diagnosis: Differentiating Priapism Types
Before initiating treatment, it's critical to determine the type of priapism:
Ischemic (low-flow) priapism (95% of cases):
- Painful, rigid erection
- Corpora cavernosa are rigid, but glans penis is soft
- Medical emergency requiring immediate intervention
- Diagnostic blood gas values: PO₂ ≤30 mmHg, PCO₂ ≥60 mmHg, pH <7.25 1
Non-ischemic (high-flow) priapism (5% of cases):
Step-by-Step Treatment Algorithm for Ischemic Priapism
First-Line Treatment:
Corporal aspiration ± irrigation:
- Use 19-21 gauge butterfly needle inserted into lateral aspect of proximal penis
- Aspirate old, dark blood
- May include irrigation with normal saline
- Resolution rate: approximately 30% 1
If aspiration fails, proceed to intracavernous injection of phenylephrine:
- Dosing: 100-500 μg diluted in saline
- Maximum dose: 1 mg in one hour
- Monitor blood pressure and heart rate during administration
- Resolution rate: 43-81% 1
Second-Line Treatment (for priapism lasting 24-48 hours):
- Surgical shunting procedures:
- Start with distal shunts (cavernoglanular/corporoglanular)
- Resolution rate: 66-74%
- Fewer complications
- If distal shunts fail, consider proximal shunts
- Resolution rate: 76-77%
- Higher risk of complications (urethral fistulas, cavernositis, pulmonary embolism) 1
- Start with distal shunts (cavernoglanular/corporoglanular)
Special Considerations
Time Sensitivity
- Treatment efficacy decreases after 48 hours
- Significant risk of erectile dysfunction after 18 hours
- Permanent erectile dysfunction likely after 36 hours 1
Patients with Sickle Cell Disease or Other Hematologic Disorders
- Standard urologic management should not be delayed for disease-specific interventions
- Systemic treatments alone have poor resolution rates (0-37%) 1
- Concurrent management of underlying disease while treating priapism directly 1, 3
Patients with Renal Failure
- Use lower doses of phenylephrine (50-100 μg) diluted in saline
- Maximum total dose reduced to 500 μg in an hour
- Phenylephrine is preferred over other sympathomimetics due to lower cardiovascular side effects 1
Management of Non-Ischemic Priapism
- Not a medical emergency
- Often resolves spontaneously (up to 62% of cases)
- Initial management: observation, ice, site-specific compression
- If treatment requested: selective arterial embolization
Common Pitfalls to Avoid
Delayed treatment: Each hour increases risk of permanent erectile dysfunction 1
Misdiagnosis: Failure to differentiate between ischemic and non-ischemic priapism can lead to inappropriate treatment 1, 4
Inadequate monitoring: Close monitoring of cardiovascular parameters during sympathomimetic administration is essential 1
Relying solely on systemic treatments in patients with underlying disorders like sickle cell disease 1, 3
Failure to inform patients about the high risk of erectile dysfunction with prolonged priapism 1